Click on headlines below to download research

ASLAN acquires full rights to varlitinib
ASLAN Pharmaceuticals | 10/01/2018

In January 2018, ASLAN announced that it had fully acquired the global commercial rights to varlitinib from its partner, Array BioPharma. Previously, the…

Novel treatments for worldwide unmet needs
ASLAN Pharmaceuticals | 07/11/2017

We are initiating coverage on ASLAN Pharmaceuticals, a clinical-stage drug developer focusing on in-licensing drugs with a high prevalence in Asia that…